510(k) K162593
K162593 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Operations (Rdo) for the device "HDL-Cholesterol Gen.4". The FDA issued a decision of Substantially Equivalent on October 19, 2016. The device falls under product code LBS (Ldl & Vldl Precipitation, Cholesterol Via Esterase-Oxidase, Hdl), a Class I device regulated under 21 CFR 862.1475. Roche Diagnostics Operations (Rdo) has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 19, 2016
- Date Received
- September 16, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Ldl & Vldl Precipitation, Cholesterol Via Esterase-Oxidase, Hdl
- Device Class
- Class I
- Regulation Number
- 862.1475
- Review Panel
- CH
- Submission Type